Drugs / SafeTynadol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03451487 | May → Dec 2022 | paracetamol poisoning | Sinew Pharma Inc. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05842733 Comparator | Jul 2023 → Dec 2024 | neuropathy, painful | Sinew Pharma Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SafeTynadol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03451487 ↗ |
| Route | Oral | “will be orally administered” NCT03451487 ↗ |